Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 prevents CCl4-induced liver cirrhosis by protecting the intestinal barrier in rats. β
Go to Publication β
Scientific reports (Sci Rep ) Vol: 7 Issue 1 Pages: 6927 Pub: 2017 Jul 31 Epub: 2017 Jul 31 Authors Shi D , Lv L , Fang D , Wu W , Hu C , Xu L , Chen Y , Guo J , Hu X , Li A , Guo F , Ye J , Li Y , Andayani D , Li L , |
|
|
Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 prevents CCl4-induced liver cirrhosis by protecting the intestinal barrier in rats. β
Go to Publication β
Scientific reports (Sci Rep ) Vol: 7 Issue 1 Pages: 6927 Pub: 2017 Jul 31 Epub: 2017 Jul 31 Authors Shi D , Lv L , Fang D , Wu W , Hu C , Xu L , Chen Y , Guo J , Hu X , Li A , Guo F , Ye J , Li Y , Andayani D , Li L , |
|
|
Assessing the Probiotic Effects of Pediococcus pentosaceus CACC616 in Weaned Piglets. β
Microorganisms (Microorganisms ) Vol: 11 Issue 12 Pages: Pub: 2023 Nov 30 Epub: 2023 Nov 30 Authors Park S , Song J , Park MA , Jang HJ , Son S , Kim DH , Kim Y , |
|
|
Correction: Influence of different culture media on the antimicrobial activity of pediococcus pentosaceus ST65ACC against listeria monocytogenes. β
Go to Publication β
Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] (Braz J Microbiol ) Vol: Issue Pages: Pub: 2024 Jun 25 Epub: 2024 Jun 25 Authors Oliveira FS , da Silva Rodrigues R , Cavicchioli VQ , de Carvalho AF , Nero LA , |
|
|
Potential Health Benefits of Yeast-Leavened Bread Containing LAB Pediococcus pentosaceus Fermented Pitaya (Hylocereus undatus): Both In Vitro and In Vivo Aspects. β
Go to Publication β
Foods (Basel, Switzerland) (Foods ) Vol: 11 Issue 21 Pages: Pub: 2022 Oct 28 Epub: 2022 Oct 28 Authors Omedi JO , Li N , Chen C , Cheng X , Huang J , Zhang B , Gao T , Liang L , Zhou Z , Huang W , |
|
|
Modulation of Intestinal Barrier, Inflammatory Response, and Gut Microbiota by Pediococcus pentosaceus zy-B Alleviates Vibrio parahaemolyticus Infection in C57BL/6J Mice. β
Go to Publication β
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 70 Issue 6 Pages: 1865-1877 Pub: 2022 Feb 16 Epub: 2022 Feb 2 Authors Wang R , Deng Y , Zhang Y , Li X , Sun L , Deng Q , Liu Y , Gooneratne R , Li J , |
|
|
Pediococcus pentosaceus CECT 8330 protects DSS-induced colitis and regulates the intestinal microbiota and immune responses in mice. β
Go to Publication β
Journal of translational medicine (J Transl Med ) Vol: 20 Issue 1 Pages: 33 Pub: 2022 Jan 15 Epub: 2022 Jan 15 Authors Dong F , Xiao F , Li X , Li Y , Wang X , Yu G , Zhang T , Wang Y , |
|
|
New strain of Pediococcus pentosaceus alleviates ethanol-induced liver injury by modulating the gut microbiota and short-chain fatty acid metabolism. β
Go to Publication β
World journal of gastroenterology (World J Gastroenterol ) Vol: 26 Issue 40 Pages: 6224-6240 Pub: 2020 Oct 28 Epub: Authors Jiang XW , Li YT , Ye JZ , Lv LX , Yang LY , Bian XY , Wu WR , Wu JJ , Shi D , Wang Q , Fang DQ , Wang KC , Wang QQ , Lu YM , Xie JJ , Li LJ , |
|
|
Effects of dietary supplementation of Pediococcus pentosaceus strains from kimchi in weaned piglet challenged with Escherichia coli and Salmonella enterica. β
Go to Publication β
Journal of animal science and technology (J Anim Sci Technol ) Vol: 65 Issue 3 Pages: 611-626 Pub: 2023 May Epub: 2023 May 31 Authors Song D , Lee J , Kim K , Oh H , An J , Chang S , Cho H , Park S , Jeon K , Yoon Y , Yoo Y , Cho Y , Cho J , |
|
|
Effects of dietary supplementation of Pediococcus pentosaceus strains from kimchi in weaned piglet challenged with Escherichia coli and Salmonella enterica. β
Go to Publication β
Journal of animal science and technology (J Anim Sci Technol ) Vol: 65 Issue 3 Pages: 611-626 Pub: 2023 May Epub: 2023 May 31 Authors Song D , Lee J , Kim K , Oh H , An J , Chang S , Cho H , Park S , Jeon K , Yoon Y , Yoo Y , Cho Y , Cho J , |
|
|
Pediococcus pentosaceus B49 from human colostrum ameliorates constipation in mice. β
Go to Publication β
Food & function (Food Funct ) Vol: 11 Issue 6 Pages: 5607-5620 Pub: 2020 Jun 24 Epub: Authors Huang J , Li S , Wang Q , Guan X , Qian L , Li J , Zheng Y , Lin B , |
|
|
Pediococcus pentosaceus B49 from human colostrum ameliorates constipation in mice. β
Go to Publication β
Food & function (Food Funct ) Vol: 11 Issue 6 Pages: 5607-5620 Pub: 2020 Jun 24 Epub: Authors Huang J , Li S , Wang Q , Guan X , Qian L , Li J , Zheng Y , Lin B , |
|
|
Pediococcus pentosaceus B49 from human colostrum ameliorates constipation in mice. β
Go to Publication β
Food & function (Food Funct ) Vol: 11 Issue 6 Pages: 5607-5620 Pub: 2020 Jun 24 Epub: Authors Huang J , Li S , Wang Q , Guan X , Qian L , Li J , Zheng Y , Lin B , |
|
|
Pediococcus pentosaceus B49 from human colostrum ameliorates constipation in mice. β
Go to Publication β
Food & function (Food Funct ) Vol: 11 Issue 6 Pages: 5607-5620 Pub: 2020 Jun 24 Epub: Authors Huang J , Li S , Wang Q , Guan X , Qian L , Li J , Zheng Y , Lin B , |
|
|
Pediococcus pentosaceus B49 from human colostrum ameliorates constipation in mice. β
Go to Publication β
Food & function (Food Funct ) Vol: 11 Issue 6 Pages: 5607-5620 Pub: 2020 Jun 24 Epub: Authors Huang J , Li S , Wang Q , Guan X , Qian L , Li J , Zheng Y , Lin B , |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
